- Home
- HCM vs FMC Comparison
HCM vs FMC Comparison
Compare HCM & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCM | FMC |
|---|---|---|
| Founded | 2000 | 1910 |
| Country | Hong Kong | United States |
| Employees | 1796 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | HCM | FMC |
|---|---|---|
| Price | $10.96 | $11.85 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 1 | 13 |
| Target Price | $13.75 | ★ $18.50 |
| AVG Volume (30 Days) | 57.4K | ★ 2.7M |
| Earning Date | 03-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,727,800,000.00 |
| Revenue This Year | $20.60 | $7.89 |
| Revenue Next Year | $15.62 | $4.54 |
| P/E Ratio | $5.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.40 | $10.72 |
| 52 Week High | $19.50 | $44.68 |
Technical Indicators
Market Signals| Indicator | HCM | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 32.71 | 41.70 |
| Support Level | N/A | N/A |
| Resistance Level | $15.59 | $14.31 |
| Average True Range (ATR) | 0.33 | 0.65 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 35.26 | 36.44 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
About FMC FMC Corporation
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.